DEA issues 4th extension of telehealth controlled substance flexibilities as debate enters 6th year - Fierce Healthcare
DEA extends telehealth controlled substance flexibilities for the 4th time, maintaining current allowances for remote prescribing of controlled substances without an in-person visit through 2025.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Current flexibilities extended through 2025; monitor for further updates.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The DEA has issued a 4th extension of the flexibilities that allow prescribing of controlled substances via telehealth without an initial in-person visit. The extension maintains the status quo through 2025, delaying any new restrictions.
Who it affects
Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers
What you must do
No immediate action required; continue operating under current flexibilities. However, prepare for potential future rulemaking by ensuring compliance with existing state and federal requirements.
Deadline
Current flexibilities extended through 2025; monitor for further updates.
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- DEA Proposes a Special Registry for Telehealth Providers of Controlled Substances - MedPage Today
- DEA Releases Long-Awaited Telehealth Special Registration Proposal, but Adoption Is Uncertain - McDermott+
- DEA Extends Telemedicine Flexibilities for Ketamine Prescribing: What Clinics Need to Know in 2026 - JD Supra
- Georgia medical board will limit virtual prescriptions - Atlanta Journal-Constitution
- DEA Proposed Telemedicine Prescribing Rule Could Burden Hospice Physicians and Hospice Operations - Morgan Lewis